Hemodialysis neutropenia and dialyzer reuse: role of the cleansing agent.

As part of a study to evaluate the safety and efficacy of dialyzer reuse, a comparative study of two methods of dialyzer reprocessing, manual and automated, was conducted. Five stable end-stage renal disease patients on center hemodialysis were evaluated as to hematological and metabolic parameters throughout two series of three consecutive dialyses using first new and then reused dialyzers reprocessed according to each of the two methods. New dialyzers and reused dialyzers following automated reprocessing always induced a profound fall in circulating neutrophil counts shortly after the start of dialysis. Hemodialysis neutropenia was not observed, however, with reused dialyzers reprocessed manually unless the concentration of sodium hypochlorite (bleach) employed was made equal to that required in automated reprocessing by being raised from 1.0 to 4.3%. It would be reasonable to conclude from these results that among the various differences between the two dialyzer reprocessing methods, restoration of the original level of biocompatibility of the reused dialyzer's membrane is related to the concentration of the cleansing agent.

[1]  D. Kerr,et al.  Membrane-induced leucopenia. , 1983, Contributions to nephrology.

[2]  V. Pollak,et al.  Multiple use of dialyzers: safety and efficacy. , 1981, Kidney international.

[3]  E. Lowrie,et al.  Effect of dialyzer reuse on leukopenia, hypoxemia and total hemolytic complement system. , 1980, Transactions - American Society for Artificial Internal Organs.

[4]  N. Levin,et al.  Leukopenia and hypoxemia. Unrelated effects of hemodialysis. , 1979, Archives of internal medicine.

[5]  G. Camussi,et al.  Leukocyte behaviour in chronic uraemic patients undergoing regular dialysis , 1979, La Ricerca in clinica e in laboratorio.

[6]  E. Friedman,et al.  Use of fluorescent antisera (FAS) to identify blood components deposited on dialyzer membranes. , 1978, Transactions - American Society for Artificial Internal Organs.

[7]  P. Vincent,et al.  Modified neutropenic response to re-used dialyzers in patients with chronic renal failure. , 1977, Clinical nephrology.

[8]  J. White,et al.  Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. , 1977, The Journal of clinical investigation.

[9]  R S Kronenberg,et al.  Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. , 1977, The New England journal of medicine.

[10]  B. A. Shinoda,et al.  Blood components deposited on used and reused dialysis membranes. , 1976, Biomaterials, medical devices, and artificial organs.

[11]  K. Nolph,et al.  Adherence of blood components to dialyzer membranes: morphological studies. , 1974, Nephron.

[12]  K. Jobbins,et al.  Observations on neutropenia associated with haemodialysis , 1969, British medical journal.

[13]  A. Gordon,et al.  Leukocyte dynamics with three types of hemodialyzers. , 1969, Transactions - American Society for Artificial Internal Organs.

[14]  J. Goffinet,et al.  Profound neutropenia during the early phase of hemodialysis. , 1968, JAMA.

[15]  S. Shaldon,et al.  Technique of Refrigerated Coil Preservation Haemodialysis with Femoral Venous Catheterization , 1964, British medical journal.